首页> 美国卫生研究院文献>Aging (Albany NY) >DR region specific antibody ameliorated but ouabain worsened renal injury in nephrectomized rats through regulating NaK-ATPase mediated signaling pathways
【2h】

DR region specific antibody ameliorated but ouabain worsened renal injury in nephrectomized rats through regulating NaK-ATPase mediated signaling pathways

机译:DR区域特异性抗体通过调节NaK-ATPase介导的信号通路而改善了肾切除后大鼠的肾损伤但哇巴因加剧了肾脏损伤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Reduced Na+-K+-ATPase function is reported in various renal diseases. This implies that increase of Na+-K+-ATPase function may be a new target in treatment of renal injury. We previously reported that Na+-K+-ATPase was stabilized by DRm217, a specific antibody against DR region of Na+-K+-ATPase. In this study, we compared the protective effect of DRm217 and ouabain on kidney in a chronic kidney disease rat model and investigated the mechanism under it. We found that DRm217 improved renal function, alleviated glomerulus atrophy, inhibited renal tubular cells apoptosis, tubulointerstitial injury and renal fibrosis in 5/6 nephrectomized rats. Contrary to DRm217, ouabain worsened renal damage. Activated Na+-K+-ATPase /Src signaling pathway, increased oxidant stress and activated inflammasome were responsible for nephrectomized or ouabain-induced renal injury. DRm217 inhibited Na+-K+-ATPase /Src signaling pathway, retarded oxidant stress, suppressed inflammasome activation, and improved renal function, suggesting a novel approach to prevent renal damage.
机译:据报道,在各种肾脏疾病中,Na + -K + -ATPase功能降低。这提示Na + -K + -ATPase功能的增强可能是治疗肾脏损伤的新靶点。先前我们曾报道过Nam + sup--K + -ATPase被DRm217稳定,DRm217是一种针对Na + -K + -ATPase。在这项研究中,我们比较了DRm217和哇巴因对慢性肾脏病大鼠模型肾脏的保护作用,并研究了其机制。我们发现DRm217改善了5/6肾切除大鼠的肾功能,减轻了肾小球萎缩,抑制了肾小管细胞凋亡,肾小管间质损伤和肾纤维化。与DRm217相反,哇巴因使肾脏损害加重。 Na + -K + -ATPase / Src信号通路活化,氧化应激增加和炎症小体活化是肾切除或哇巴因引起的肾损伤的原因。 DRm217抑制Na + -K + -ATPase / Src信号通路,抑制氧化应激,抑制炎症小体活化,改善肾功能,提示了一种预防肾脏损害的新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号